Health experts warn no single type of product can treat all kinds of eye diseases, refuting false social media advertisements ...

More recently established treatments for RVO have taken a giant leap forward from laser photocoagulation since intravitreally ...

Chief Executive Officer Craig Parker used a discussion at a 2026 investor summit to outline the company’s focus on Wnt pathway biology and antibody engineering, with an emphasis on retinal vascular ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid ...

Sunir Garg, MD, expresses excitement about attending AAO 2025 and focuses on several topics to be discussed. These include the benefits and potential vision risks of GLP-1 inhibitors in patients with ...

National Institutes of Health (NIH) researchers have developed a digital replica of crucial eye cells, providing a new tool ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully replicates the structural layers and microvascular network of the human ...

In a genetic association study, investigators integrated data from genome-wide association studies of various disorders with retinal transcriptomic data. Findings revealed that the polygenic risk of ...

Rahul Tonk, MD, MBA attended Envision Summit 2026 to present on refractive surgery, dry eye, and ocular surface disease. In the CE Spotlight Symposium titled “Emerging Therapeutic Advancements in Dry ...